Replies to post #264156 on Avid Bioservices Inc (CDMO)

[Carboat]

Good to have these collaborations but ...MSK and NCCN are being paid for this so very low bar there. AZN is providing drugs but no money. You may have noticed these activities have provided no support for pphm shareprice.

[InternetForumUser]

MSK: Isn't Peregrine funding this collaboration?

NCCN: Isn't Peregrine funding this collaboration?

AZN: Isn't Peregrine funding all but the cost of the drug Durvalumab? I know many have surmised the value of the Durvalumab contribution but no one here knows.

The only puzzle pieces that you have put together so far, is a tangled mess of ramblings outlining every possible scenario that could exist and then some.

Sabotage... You all need to drop it.. Even if it was, it was never proven and Peregrine settled for $600K. So basically, under your assumptions, pretty much EVERY PEREGRINE Trial has been sabotaged. go figure.

Review the Management Team and BOD.. Their BIOS's should give you enough information as to why they continue to stumble and fumble.